Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Pharmacogenetic study of statin therapy and cholesterol reduction.

× No keyword cloud information.

9 in total

1. Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation/CRP evaluation (PRINCE): a randomized trial and cohort study.

Authors: M A Albert; E Danielson; N Rifai; P M Ridker
Journal: JAMA Date: 2001-07-04 Impact factor: 56.272

2. Association of cholesteryl ester transfer protein-TaqIB polymorphism with variations in lipoprotein subclasses and coronary heart disease risk: the Framingham study.

Authors: J M Ordovas; L A Cupples; D Corella; J D Otvos; D Osgood; A Martinez; C Lahoz; O Coltell; P W Wilson; E J Schaefer
Journal: Arterioscler Thromb Vasc Biol Date: 2000-05 Impact factor: 8.311

3. Cholesteryl ester transfer protein TaqIB variant, high-density lipoprotein cholesterol levels, cardiovascular risk, and efficacy of pravastatin treatment: individual patient meta-analysis of 13,677 subjects.

Authors: S M Boekholdt; F M Sacks; J W Jukema; J Shepherd; D J Freeman; A D McMahon; F Cambien; V Nicaud; G J de Grooth; P J Talmud; S E Humphries; G J Miller; G Eiriksdottir; V Gudnason; H Kauma; S Kakko; M J Savolainen; M Arca; A Montali; S Liu; H J Lanz; A H Zwinderman; J A Kuivenhoven; J J P Kastelein
Journal: Circulation Date: 2005-01-17 Impact factor: 29.690

4. Extensive association analysis between the CETP gene and coronary heart disease phenotypes reveals several putative functional polymorphisms and gene-environment interaction.

Authors: M Corbex; O Poirier; F Fumeron; D Betoulle; A Evans; J B Ruidavets; D Arveiler; G Luc; L Tiret; F Cambien
Journal: Genet Epidemiol Date: 2000-07 Impact factor: 2.135

5. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators.

Authors: F M Sacks; M A Pfeffer; L A Moye; J L Rouleau; J D Rutherford; T G Cole; L Brown; J W Warnica; J M Arnold; C C Wun; B R Davis; E Braunwald
Journal: N Engl J Med Date: 1996-10-03 Impact factor: 91.245

6. The role of a common variant of the cholesteryl ester transfer protein gene in the progression of coronary atherosclerosis. The Regression Growth Evaluation Statin Study Group.

Authors: J A Kuivenhoven; J W Jukema; A H Zwinderman; P de Knijff; R McPherson; A V Bruschke; K I Lie; J J Kastelein
Journal: N Engl J Med Date: 1998-01-08 Impact factor: 91.245

7. Haplotype analysis of the CETP gene: not TaqIB, but the closely linked -629C-->A polymorphism and a novel promoter variant are independently associated with CETP concentration.

Authors: Anke H E M Klerkx; Michael W T Tanck; John J P Kastelein; Henri O F Molhuizen; J Wouter Jukema; Aeilko H Zwinderman; Jan Albert Kuivenhoven
Journal: Hum Mol Genet Date: 2003-01-15 Impact factor: 6.150

8. Cholesteryl ester transfer protein TaqI B2B2 genotype is associated with higher HDL cholesterol levels and lower risk of coronary heart disease end points in men with HDL deficiency: Veterans Affairs HDL Cholesterol Intervention Trial.

Authors: Margaret E Brousseau; John J O'Connor; Jose M Ordovas; Dorothea Collins; James D Otvos; Tatyana Massov; Judith R McNamara; Hanna B Rubins; Sander J Robins; Ernst J Schaefer
Journal: Arterioscler Thromb Vasc Biol Date: 2002-07-01 Impact factor: 8.311

9. Common genetic variation of the cholesteryl ester transfer protein gene strongly predicts future cardiovascular death in patients with coronary artery disease.

Authors: Stefan Blankenberg; Hans J Rupprecht; Christoph Bickel; Xian-Cheng Jiang; Odette Poirier; Karl J Lackner; Jürgen Meyer; François Cambien; Laurence Tiret
Journal: J Am Coll Cardiol Date: 2003-06-04 Impact factor: 24.094

9 in total